Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny incision, big relief? ultrasound procedure challenges carpal tunnel surgery

NCT ID NCT07668310

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study compared a new, minimally invasive ultrasound-guided procedure to standard surgery for carpal tunnel syndrome. The goal was to see if the new technique could provide similar relief with a smaller incision and faster recovery. Only 7 people were enrolled before the study was stopped early, so the results are not conclusive.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound-guided percutaneous carpal tunnel release procedure
What this could lead to
If it works, this could offer a less invasive option for carpal tunnel syndrome, with faster recovery and less pain than traditional surgery.
What could go wrong
This trial was terminated early with only 7 participants, so results are very limited. The new procedure may not be as effective or safe as standard surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

7 people

The number who actually took part.

Started

Jan 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient, male or female, over 18 years of age * Patient with clinical carpal tunnel syndrome * Patient with unilateral or bilateral carpal tunnel syndrome. In the case of bilateral involvement, the more symptomatic hand (with the highest Boston score) will be included, with the patient agreeing that the second hand will not be operated on within one year. * Patient with carpal tunnel syndrome confirmed by an EMG less than 6 months old * Patient with carpal tunnel syndrome without motor or sensory deficits * Patient with carpal tunnel syndrome resistant to conservative treatment, including at least one corticosteroid injection * Patient agreeing to undergo surgery * Patient affiliated with or covered by a social security plan * Patient who has been informed and has signed a free and informed written consent. Exclusion Criteria: * Patient with another condition of the hand or wrist (Dupuytren's disease, inflammatory rheumatism, symptomatic osteoarthritis) * Patient with a history of previous hand or wrist surgery requiring treatment * Neurological sequelae of the hand * Patient with non-medicinal hypocoagulation or vitamin K antagonist overdose * Patient with a known allergy to lidocaine * Patient with an unhealed palmo-digital wound * Patient with a superficial or deep palmo-digital infection or inflammation * Patient who has received a cortisone injection in the hand or wrist within the last month. - Patient with type 1 diabetes or poorly controlled diabetes (HbA1c \>7.5% for less than 3 months) * Patient with cognitive impairment deemed incompatible with the research by the investigator * Patient with a language barrier preventing a reliable assessment * Patient participating in another clinical trial * Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, breastfeeding, or postpartum woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Lariboisière

    Paris, 75010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.